Geroscience in the Age of COVID-19

The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling th...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzilai, Nir, Appleby, James C, Austad, Steven N, Cuervo, Ana Maria, Kaeberlein, Matt, Gonzalez-Billault, Christian, Lederman, Stephanie, Stambler, Ilia, Sierra, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390533/
https://www.ncbi.nlm.nih.gov/pubmed/32765937
http://dx.doi.org/10.14336/AD.2020.0629
Descripción
Sumario:The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling the present crisis and is expected to be relevant when tackling future infections, epidemics and pandemics. Therefore, utilizing a geroscience approach, targeting aging processes to prevent multimorbidity, via initiating broad clinical trials of potential geroprotective therapies, is recommended.

Ejemplares similares